← Back to Search

3D translabial ultrasound for Pelvic Organ Prolapse

N/A
Waitlist Available
Research Sponsored by Western University, Canada
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
are willing to remove their pessary two days before the ultrasound examination date
are current pessary users (> 6 months) who have no pessary related complication, including discomfort, vaginal bleeding, and pessary extrusion
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 hour and 20 minutes (i.e. the estimated time for the ultrasound and manometry examination per participant).
Awards & highlights

Study Summary

This is a feasibility study looking at the use of 3D ultrasound with vaginal manometry at various distension volumes to predict the best available pessary for successful fit.

Eligible Conditions
  • Pelvic Organ Prolapse

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 hour and 20 minutes (i.e. the estimated time for the ultrasound and manometry examination per participant).
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 hour and 20 minutes (i.e. the estimated time for the ultrasound and manometry examination per participant). for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Ultrasonography
Secondary outcome measures
Survey

Trial Design

1Treatment groups
Experimental Treatment
Group I: 3D translabial ultrasoundExperimental Treatment1 Intervention
3D translabial ultrasound with concurrent vaginal manometry

Find a Location

Who is running the clinical trial?

Western University, CanadaLead Sponsor
238 Previous Clinical Trials
57,147 Total Patients Enrolled
Cosm Medical CorporationUNKNOWN

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~7 spots leftby Mar 2025